• Exchange: Munich
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

CSJ:GR

45.193 EUR 0.379 0.85%

As of 02:59:24 ET on 04/16/2014.

Snapshot for CSL Ltd (CSJ)

Open: 45.400 Day's Range: 45.193 - 46.145 Volume: 0
Previous Close: 44.814 52wk Range: 39.813 - 50.190 1-Yr Rtn: -2.21%

Stock Chart for CSJ

No chart data available.
  • CSJ:GR 45.193
  • 1D
  • 1M
  • 1Y
44.814
Interactive CSJ Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CSJ

Current P/E Ratio (ttm) -
Estimated P/E(06/2014) 22.4682
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (06/2014) 2.7820
Est. PEG Ratio 1.7860
Market Cap (M EUR) 21,857.13
Shares Outstanding (M) 483.64
30 Day Average Volume 23
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 1.72%
Cash Dividend (AUD) 0.5888
Dividend Ex-Date 03/05/2014
5 Year Dividend Growth 22.67%
Next Earnings Announcement 08/14/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CSJ

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CSJ

CSL Limited develops, manufactures and markets human pharmaceutical and diagnostic products derived from human plasma. The Company's products include pediatric and adult vaccines, infection and pain medicine, skin disorder remedies, antivenoms, anticoagulants and immunoglobulins.

John ShineChairmanPaul PerreaultCEO/Managing Director
Gordon NaylorChief Financial OfficerGregory Boss "Greg"Exec VP:Legal/Gen Cnsl
More Company Profile & Key Executives for CSJ

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil